Page last updated: 2024-12-10

dezocine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dezocine: potent analgesic; RN given refers to ((5R-(5alpha,11alpha,13S*)))-isomer (dezocin); structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

dezocine : (7S,8S)-7-Amino-8-methyl-5,6,7,8-tetrahydronaphthalen-2-ol in which the hydrogen at position 8 and one of the hydrogens at position 6 are substituted by each end of a tetramethylene bridge. A synthetic opioid analgesic, it has mixed opiod agonist and antagonist properties. Although it is used for pain management, it can produce opioid withdrawal syndrome in patients already dependent on other opioids, and its clinical application is limited by side effects such as dizziness. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3033053
CHEMBL ID1685
CHEBI ID4474
SCHEMBL ID3072
MeSH IDM0056650

Synonyms (52)

Synonym
dalgan
wy-16225
dezocina [inn-spanish]
wy-16,225
13-amino-5,6,7,8,9,10,11,12-octahydro-5-methyl-5,11-methanobenzocyclodecenol
5,11-methanobenzocyclodecen-3-ol, 13-amino-5,6,7,8,9,10,11,12-octahydro-5-methyl-, (5alpha,11alpha,13s*)-, (-)-
dezocine [usan:inn]
dezocinum [inn-latin]
wy 16225
wy 16,225
dezocine
53648-55-8
C08010
(-)-13beta-amino-5,6,7,8,9,10,11alpha,12-octahydro-5alpha-methyl-5,11-methanobenzocyclodecen-3-ol
DB01209
dezocine (usan)
D00838
dalgan (tn)
CHEBI:4474 ,
(5r,11s,13s)-13-amino-5-methyl-5,6,7,8,9,10,11,12-octahydro-5,11-methanobenzocyclodecen-3-ol
dezocinum
dezocina
bdbm50276568
dozocine
CHEMBL1685 ,
docozine
AKOS016014025
unii-vhx8k5sv4x
vhx8k5sv4x ,
dezocine [who-dd]
dezocine [mi]
dezocine [usan]
dezocine [orange book]
dezocine [vandf]
(-)-13.beta.-amino-5,6,7,8,9,10,11.alpha.,12-octahydro-5.alpha.-methyl-5,11-methanobenzocyclodecen-3-ol
dezocine [inn]
5,11-methanobenzocyclodecen-3-ol, 13-amino-5,6,7,8,9,10,11,12-octahydro-5-methyl-, (5.alpha.,11.alpha.,13s*)
dezocine [mart.]
SCHEMBL3072
DTXSID2022911 ,
(1r,9s,15s)-15-amino-1-methyltricyclo[7.5.1.0^{2,7}]pentadeca-2,4,6-trien-4-ol
(1r,9s,15s)-15-amino-1-methyltricyclo[7.5.1.02,7]pentadeca-2(7),3,5-trien-4-ol
Q1109018
EN300-27032797
(1r,9s,15s)-15-amino-1-methyltricyclo[7.5.1.0,2,7]pentadeca-2,4,6-trien-4-ol
dtxcid702911
5,11-methanobenzocyclodecen-3-ol, 13-amino-5,6,7,8,9,10,11,12-octahydro-5-methyl-, (5alpha,11alpha,13s*)
5,11-methanobenzocyclodecen-3-ol, 5,6,7,8,9,10,11,12-octahydro-13-amino-5-methyl-
n02ax03
dezocinum (inn-latin)
dezocina (inn-spanish)
dezocine (mart.)

Research Excerpts

Overview

Dezocine is a powerful analgesic that can be less addictive than morphine, yet how the two drugs interact in vivo is poorly understood. It is considered to be an alternative medication for managing postoperative pain.

ExcerptReferenceRelevance
"Dezocine is an opioid analgesic that can affect the immune system. "( High Concentration of Dezocine Induces Immune Escape of Lung Cancer and Promotes Glucose Metabolism through Up-Regulating PD-L1 and Activating the NF-κB Pathway.
Dong, W; Hu, Y; Li, W; Zhang, D; Zhu, A, 2022
)
2.48
"Dezocine is a partial mu opioid receptor agonist previously used as an analgesic for perioperative acute pain in the US and is now the most used perioperative analgesic in China. "( A new formulation of dezocine, Cyc-dezocine, reduces oxycodone self-administration in female and male rats.
Barr, GA; Liu, R; Schmidt, HD; Xi, J; Zanni, G; Zhang, Y, 2023
)
2.67
"Dezocine is an opioid analgesic with both μ-receptor agonist and antagonist activities. "( Dezocine promotes T lymphocyte activation and inhibits tumor metastasis after surgery in a mouse model.
Feng, C; Liu, D; Liu, G; Song, Q, 2020
)
3.44
"Dezocine is an analgesic, acting as partial antagonist of κ-receptors and agonist of μ-receptors."( Dezocine prevents sufentanil-induced cough during general anesthesia induction: a meta-analysis of randomised controlled trials.
Song, J; Tan, M; Xiong, Z; Yi, P, 2020
)
2.72
"Dezocine is an opioid with low efficacy at μ-opioid and κ-opioid receptors. "( Antidepressant-like effects of dezocine in mice: involvement of 5-HT1A and κ opioid receptors.
Chang, N; Chang, S; Duan, C; Jia, S; Shang, L, 2021
)
2.35
"Dezocine is a powerful analgesic that can be less addictive than morphine, yet how the two drugs interact in vivo is poorly understood. "( Dezocine Antagonizes Morphine Analgesia upon Simultaneous Administration in Rodent Models of Acute Nociception.
Guo, CL; Guo, SH; Huang, LE; Huang, YQ; Li, NN; Shen, MR; Yao, YX; Zhu, SM, 2017
)
3.34
"Dezocine is considered to be an alternative medication for managing postoperative pain. "( Dezocine for Preventing Postoperative Pain: A Meta-Analysis of Randomized Controlled Trials.
Wang, M; Yan, M; Yu, L; Zhang, C; Zhou, X, 2015
)
3.3
"Dezocine is a promising analgesic for preventing postoperative pain, but further studies are required to evaluate its safety."( Dezocine for Preventing Postoperative Pain: A Meta-Analysis of Randomized Controlled Trials.
Wang, M; Yan, M; Yu, L; Zhang, C; Zhou, X, 2015
)
3.3
"Dezocine is an opioid mu-partial agonist recently approved for use as an analgesic in the United States. "( Opioid antagonist effects of dezocine in opioid-dependent humans.
Bigelow, GE; Liebson, IA; Preston, KL; Strain, EC, 1996
)
2.03
"Dezocine is an agonist-antagonist opiate that acts at the mu receptor, and is used for management of pain. "( Subjective, behavioral, and physiologic responses to intravenous dezocine in healthy volunteers.
de Wit, H; Lichtor, JL; Zacny, JP, 1992
)
1.96
"Dezocine is an analgesic agent with opioid agonist and antagonist activity. "( Dezocine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
Benfield, P; O'Brien, JJ, 1989
)
3.16
"Dezocine is an analgesic soon to be marketed in the United States. "( Assessment of dezocine for morphine-like subjective effects and miosis.
Jasinski, DR; Preston, KL, 1985
)
2.07

Effects

Dezocine has extensive distribution, high clearance and short half-life over a range of IV doses. It is a better choice to carry out postoperative analgesia after maxillofacial procedures.

ExcerptReferenceRelevance
"Dezocine has notable analgesia effect for postoperative sore throat, so it is a better choice to carry out postoperative analgesia after maxillofacial procedures."( [Effects of dezocine on postoperative sore throat after maxillofacial procedures: a comparison with flurbiprofen axetil].
Jiao, L; Liu, RC, 2014
)
2.22
"Dezocine has been generally utilized for pain therapy and auxiliary anesthesia. "( Effect of Dezocine on IL-12 and IL-10 secretion and lymphocyte activation by culturing dendritic cells from human umbilical cord blood.
Feng, C; Feng, M; Jiao, R; Jin, Y; Liu, D; Xiao, R; Zhao, X, 2017
)
2.3
"Thus dezocine has extensive distribution, high clearance and short half-life over a range of IV doses."( Pharmacokinetics of dezocine, a new analgesic: effect of dose and route of administration.
Greenblatt, DJ; Locniskar, A; Zinny, MA, 1986
)
1.05

Actions

ExcerptReferenceRelevance
"Dezocine at 8 μg/mL promotes immune escape and glucose metabolism in LC through up-regulating PD-L1 and activating the NF-κB pathway."( High Concentration of Dezocine Induces Immune Escape of Lung Cancer and Promotes Glucose Metabolism through Up-Regulating PD-L1 and Activating the NF-κB Pathway.
Dong, W; Hu, Y; Li, W; Zhang, D; Zhu, A, 2022
)
2.48

Treatment

Dezocine-treated BMDCs promoted CD8+ T cell proliferation and cytotoxicity. Treatment with dezOCine, pentazocine and tapentadol stimulated calcium mobilization in HEK293 cells stably expressed MORs.

ExcerptReferenceRelevance
"Dezocine-treated BMDCs promoted CD8+ T cell proliferation and cytotoxicity, while dezocine treatment inhibited tumor metastasis in mice."( Dezocine promotes T lymphocyte activation and inhibits tumor metastasis after surgery in a mouse model.
Feng, C; Liu, D; Liu, G; Song, Q, 2020
)
2.72
"Treatment with dezocine, pentazocine and tapentadol stimulated calcium mobilization in HEK293 cells stably expressed MORs but not KORs, whereas dezocine and pentazocine inhibited KOR activities. "( Comparative study of dezocine, pentazocine and tapentadol on antinociception and physical dependence.
Ahsan, MZ; Shoaib, RM; Wang, YX; Zhang, Y; Zhao, MJ, 2021
)
1.29
"Pretreatment with dezocine significantly reduced both the incidence and intensity of myoclonus."( Intravenous dezocine pretreatment reduces the incidence and intensity of myoclonus induced by etomidate.
Cheng, Z; Dong, T; Fang, J; Jiang, S; Li, A; Li, F; Liang, B; Lu, Z; Lv, Z; Zhu, J, 2014
)
1.1

Toxicity

15 mg/kg dezocine 15 min before gynecological laparoscopic surgery showed better analgesic and sedative effects as well as less adverse reactions. VAS score, Ramsay score and MMSE score were used to evaluate the efficacy and safety.

ExcerptReferenceRelevance
"5 million adverse drug reaction (ADR) reports for 8620 drugs/biologics that are listed for 1191 Coding Symbols for Thesaurus of Adverse Reaction (COSTAR) terms of adverse effects."( Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL, 2004
)
0.32
" VAS score, Ramsay score and MMSE score were used to evaluate the efficacy and safety of dezocine in preemptive analgesia and sedation, and the use of adjuvant analgesic drugs and the incidence of adverse reactions were also observed."( Efficacy and safety of different doses of dezocine for preemptive analgesia in gynecological laparoscopic surgeries: A prospective, double blind and randomized controlled clinical trial.
Sun, B; Wang, J; Wang, L; Wang, R; Wu, C; Yan, L; Zhou, M,
)
0.62
" There were no significant differences in the incidence of adverse events between the three groups (P > 0."( Efficacy and safety of different doses of dezocine for preemptive analgesia in gynecological laparoscopic surgeries: A prospective, double blind and randomized controlled clinical trial.
Sun, B; Wang, J; Wang, L; Wang, R; Wu, C; Yan, L; Zhou, M,
)
0.4
"15 mg/kg dezocine 15 min before gynecological laparoscopic surgery showed better analgesic and sedative effects as well as less adverse reactions, and should be the appropriate dose to be used in the preemptive analgesia in gynecological laparoscopic surgeries."( Efficacy and safety of different doses of dezocine for preemptive analgesia in gynecological laparoscopic surgeries: A prospective, double blind and randomized controlled clinical trial.
Sun, B; Wang, J; Wang, L; Wang, R; Wu, C; Yan, L; Zhou, M,
)
0.81
" Opioid-induced cough (OIC) is mostly transient, benign and self-limiting, but could be associated with adverse effects."( Is dezocine effective and safe in preventing opioids-induced cough during general anaesthesia induction? A protocol for systematic review and meta-analysis.
He, LX; Ma, J; Shao, K; Yao, YT; Zhao, YY, 2020
)
1.18
" Secondary outcomes of interest include possible complications or adverse effects of DZC."( Is dezocine effective and safe in preventing opioids-induced cough during general anaesthesia induction? A protocol for systematic review and meta-analysis.
He, LX; Ma, J; Shao, K; Yao, YT; Zhao, YY, 2020
)
1.18
" We compared the hemodynamic indexes before operation, during puncturing and at 5 minutes after operation, the pain scores during the movement of the probe in the rectum, at puncturing and at 5 minutes after surgery, and the adverse reactions to anesthesia between the two groups of patients."( [Application value and safety of prostate peripheral nerve block combined with dezocine in transrectal prostate biopsy].
Cai, QF; Lu, YX, 2022
)
0.95
" The anesthesia onset time, anesthesia duration, numeric rating scale (NRS) score, anesthesia satisfaction rate and incidence of adverse reactions were recorded and compared between the two groups."( To evaluate the efficacy and safety of dezocine combined with lidocaine in local anesthesia for percutaneous testicular sperm aspiration.
Deng, ZX; Liu, JL; Liu, M; Zhu, XX, 2023
)
1.18

Pharmacokinetics

The ceiling of analgesic activity of dezocine occurs at a higher level of analgesia than that of reference agonist/antagonist agents. The pharmacokinetic properties of deZocine were examined in 15 patients with acute or chronic pain.

ExcerptReferenceRelevance
" However, preliminary pharmacodynamic data indicate that the ceiling of analgesic activity of dezocine occurs at a higher level of analgesia than that of reference agonist/antagonist agents."( Dezocine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
Benfield, P; O'Brien, JJ, 1989
)
1.94
"The pharmacokinetic properties of dezocine were examined in 15 patients with acute or chronic pain."( Single- and multiple-dose pharmacokinetics of dezocine in patients with acute or chronic pain.
Cohen, RI; Kezer, EA; Schange, SJ; Smith, ER; Wilson, JM, 1995
)
0.83

Compound-Compound Interactions

Dexmedetomidine combined with sufentanil and dezocine increased female patients' global satisfaction degree after thoracoscopic surgery.

ExcerptReferenceRelevance
" The authors aimed to investigate the efficacy of low concentrations of dezocine in combination with morphine for postoperative pain."( Low Concentration of Dezocine in Combination With Morphine Enhance the Postoperative Analgesia for Thoracotomy.
Dong, YP; Sun, L; Wu, L, 2015
)
0.97
"The morphine group (Group M) received morphine (1 mg/mL) alone for patient-controlled analgesia (PCA); the morphine+dezocine 1 group (Group MD1) received morphine (1 mg/mL) combined with dezocine (0."( Low Concentration of Dezocine in Combination With Morphine Enhance the Postoperative Analgesia for Thoracotomy.
Dong, YP; Sun, L; Wu, L, 2015
)
0.95
"To evaluate the efficacy and safety of patient-controlled intravenous analgesia (PCIA) of dezocine combined with sufentanil in burn patients after escharectomy or tangential excision followed by autologous skin grafting."( [Application of patient-controlled intravenous analgesia of dezocine combined with sufentanil in burn patients after surgery].
Li, S; Min, S; Tang, W; Wu, B, 2015
)
0.88
"Dezocine combined with sufentanil can provide effective postoperative analgesia with little adverse effect for PCIA in burn patients after escharectomy or tangential excision followed by autologous skin grafting, therefore it can be widely used."( [Application of patient-controlled intravenous analgesia of dezocine combined with sufentanil in burn patients after surgery].
Li, S; Min, S; Tang, W; Wu, B, 2015
)
2.1
"To assess the use of dezocine combined with propofol for the anesthetization of patients undergoing indolent colonoscopy."( Clinical study of anesthetization by dezocine combined with propofol for indolent colonoscopy.
Xu, BB; Xu, GP; Zhao, XL, 2016
)
1.03
"This study revealed that dezocine combined with propofol can be successfully used for the anesthetization of indolent colonoscopy patients without pain and should be widely used."( Clinical study of anesthetization by dezocine combined with propofol for indolent colonoscopy.
Xu, BB; Xu, GP; Zhao, XL, 2016
)
1.01
"To evaluate the effect of dezocine combined with propofol on painless gastroscopy in patients with suspect gastric carcinoma."( Effect of dezocine combined with propofol on painless gastroscopy in patients with suspect gastric carcinoma.
Chen, Z; Ma, C; Ma, J; Xin, W; Zhang, D; Zhang, P; Zhang, Y, 2016
)
1.14
"Dezocine combined with propofol on painless gastroscopy can reduce the respiratory depression and body movement without interference of hemodynamics."( Effect of dezocine combined with propofol on painless gastroscopy in patients with suspect gastric carcinoma.
Chen, Z; Ma, C; Ma, J; Xin, W; Zhang, D; Zhang, P; Zhang, Y, 2016
)
2.28
" This trial will evaluate the effects of propofol combined with small doses of dezocine, oxycodone, sufentanil or fentanyl for gastroscopy."( Effect of propofol combined with opioids on cough reflex suppression in gastroscopy: study protocol for a double-blind randomized controlled trial.
Cao, YZ; Lu, X; Xia, J; Xie, J; Yin, N; Yuan, J, 2017
)
0.68
"The paper aims to explore the application of dexmedetomidine combined with dezocine in thoracoscopic radical resection of lung cancer and its effect on the awakening quality."( The application of dexmedetomidine combined with dezocine in thoracoscopic radical resection of lung cancer and its effect on awakening quality of patients.
Ji, XY; Liu, R; Song, JF; Tan, HL; Yi, XL; Zhou, ZG, 2019
)
1
" Among them, 68 patients were anesthetized with dexmedetomidine combined with dezocine as a study group, 54 patients with midazolam combined with fentanyl as a control group."( The application of dexmedetomidine combined with dezocine in thoracoscopic radical resection of lung cancer and its effect on awakening quality of patients.
Ji, XY; Liu, R; Song, JF; Tan, HL; Yi, XL; Zhou, ZG, 2019
)
1
"The anesthesia effect of dexmedetomidine combined with dezocine in thoracoscopic radical resection of lung cancer is better and safer than other drugs, and it can produce good sedation and analgesic effect."( The application of dexmedetomidine combined with dezocine in thoracoscopic radical resection of lung cancer and its effect on awakening quality of patients.
Ji, XY; Liu, R; Song, JF; Tan, HL; Yi, XL; Zhou, ZG, 2019
)
1.02
"To explore the analgesic effect of dizocine combined with ropivacaine on recurrent neuropathic pain in rat model of peripheral nerve compression."( Analgesic Effect of Dizocine Combined with Ropivacaine on Recurrent Neuropathic Pain in Peripheral Nerve Compression Rats.
Chu, C; Liu, Z; Ma, C; Sun, J; Zhang, X, 2020
)
0.56
"There are no studies on the use of dexmedetomidine combined with sufentanil and dezocine-based patient-controlled intravenous analgesia (PCIA) in females undergoing thoracic surgery."( Dexmedetomidine combined with sufentanil and dezocine-based patient-controlled intravenous analgesia increases female patients' global satisfaction degree after thoracoscopic surgery.
Li, Q; Wu, J; Xu, M; Yao, H, 2021
)
1.11
"Dexmedetomidine combined with sufentanil and dezocine increased female patients' global satisfaction degree after thoracoscopic surgery."( Dexmedetomidine combined with sufentanil and dezocine-based patient-controlled intravenous analgesia increases female patients' global satisfaction degree after thoracoscopic surgery.
Li, Q; Wu, J; Xu, M; Yao, H, 2021
)
1.14
"To observe the effect of Ketorolac tromethamine combined with dezocine prior administration on hemodynamics and postoperative sedation in patients undergoing laparoscopic hernia repair."( Effect of ketorolac tromethamine combined with dezocine prior administration on hemodynamics and postoperative analgesia in patients undergoing laparoscopic hernia repair.
Cai, Z; Fu, B; Kang, Y; Li, Y; Wang, J; Wu, Y, 2022
)
1.22
"100 male patients aged 60 to 80 years old, a line to elective laparoscopic inguinal hernia repair, were randomly divided into four groups: control group (Group A) and dezocine group (Group B), ketorolac tromethamine group (Group C), ketorolac tromethamine combined with dezocine group (Group D)."( Effect of ketorolac tromethamine combined with dezocine prior administration on hemodynamics and postoperative analgesia in patients undergoing laparoscopic hernia repair.
Cai, Z; Fu, B; Kang, Y; Li, Y; Wang, J; Wu, Y, 2022
)
1.17
"The aim of this study was to explore the effects of dezocine combined with dexmedetomidine on adverse reactions and inflammatory factors in patients undergoing hyperthermic intraperitoneal chemotherapy (HIPEC) after intestinal surgery and its protective effect on the heart in the perioperative period."( Effects of dezocine combined with dexmedetomidine on adverse reactions and inflammatory factors in patients undergoing HIPEC after intestinal surgery and its protective effect on the heart in the perioperative period.
Lu, YJ; Shao, JL; Shen, R; Wang, L; Yang, ZH; Zhan, FF, 2022
)
1.36
" Meanwhile, dezocine combined with dexmedetomidine was given in the same way in the observation group."( Effects of dezocine combined with dexmedetomidine on adverse reactions and inflammatory factors in patients undergoing HIPEC after intestinal surgery and its protective effect on the heart in the perioperative period.
Lu, YJ; Shao, JL; Shen, R; Wang, L; Yang, ZH; Zhan, FF, 2022
)
1.49
"In HIPEC, dezocine combined with dexmedetomidine used for sedation and analgesia is able to effectively reduce adverse reactions and relieve inflammatory responses in vivo, exerting a cardio-protective effect."( Effects of dezocine combined with dexmedetomidine on adverse reactions and inflammatory factors in patients undergoing HIPEC after intestinal surgery and its protective effect on the heart in the perioperative period.
Lu, YJ; Shao, JL; Shen, R; Wang, L; Yang, ZH; Zhan, FF, 2022
)
1.51
"To investigate the application value and safety of peripheral prostate nerve block (PPNB) combined with dezocine in transrectal prostate biopsy."( [Application value and safety of prostate peripheral nerve block combined with dezocine in transrectal prostate biopsy].
Cai, QF; Lu, YX, 2022
)
1.16
"Using a random number table, we divided 97 patients undergoing prostate biopsy in our hospital from October 2018 to October 2020 into an experimental group (n = 49) and a control group (n = 48), the former anesthetized by PPNB combined with dezocine and the latter by PPNB only."( [Application value and safety of prostate peripheral nerve block combined with dezocine in transrectal prostate biopsy].
Cai, QF; Lu, YX, 2022
)
1.13
"PPNB combined with dezocine for prostate biopsy is more conducive to maintaining the stability of the patient's hemodynamics, and has a good analgesic effect and a high safety."( [Application value and safety of prostate peripheral nerve block combined with dezocine in transrectal prostate biopsy].
Cai, QF; Lu, YX, 2022
)
1.28
"This study aimed to determine how dexmedetomidine and dezocine interact on T lymphocytes, NK cells and cognitive function in elderly individuals with gastrointestinal cancer after radical surgery."( Effects of dexmedetomidine combined with dezocine on T lymphocytes, NK cells and cognitive function in elderly patients with gastrointestinal cancer after radical surgery.
Ai, Z, 2023
)
1.42

Bioavailability

ExcerptReferenceRelevance
"The pharmacokinetics of intravenous (IV) dezocine, and bioavailability of intramuscular (IM) and subcutaneous (SQ) dezocine, were evaluated in healthy male volunteers."( Pharmacokinetics of dezocine, a new analgesic: effect of dose and route of administration.
Greenblatt, DJ; Locniskar, A; Zinny, MA, 1986
)
0.86

Dosage Studied

ExcerptRelevanceReference
" When the scores derived from the categorized ratings 1 hour after drug dosing (generally the time of peak effect) were analyzed, there was little difference whether a parametric or nonparametric approach was taken."( Reassessment of verbal and visual analog ratings in analgesic studies.
Littman, GS; Schneider, BE; Walker, BR, 1985
)
0.27
"The analgesic effect of a single intravenous dose of dezocine at various dosage levels was studied in 41 patients suffering from acute renal colic."( Preliminary clinical experience with dezocine, a new potent analgesic.
Oosterlinck, W; Verbaeys, A, 1980
)
0.78
"Propofol infusion and supplemental fentanyl dosage requirements, oxygen saturation values, respiratory rates, recovery times, and postoperative side effects were recorded."( Use of analgesics during propofol sedation: a comparison of ketorolac, dezocine, and fentanyl.
Ramirez-Ruiz, M; Smith, I; White, PF, 1995
)
0.52
" Dose-response and time-course determinations were performed with various opioids."( Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the mu opioid receptor.
Barrett, AC; Bowman, JR; Cook, CD; Picker, MJ; Roach, EL, 2000
)
0.31
"To observe the effects of intra-operative combined dosing of dezoxine and dexmedetomidine on sedation, analgesia and the incidence of untoward events during and after surgery in teenagers undergoing horizontal concomitant strabismus surgery."( [Application of dezoxine plus dexmedetomidine in strabismus surgery].
Hu, Z; Sun, C; Ye, W, 2014
)
0.4
" Dosage of propofol required in group E (1."( The effectiveness of esketamine and propofol versus dezocine and propofol sedation during gastroscopy: A randomized controlled study.
Chen, L; Tang, T; Xu, Y; Zhang, Y; Zhang, Z; Zheng, Y, 2022
)
0.97
" Operation time, awakening time (time from drug withdrawal to consciousness recovery), the dosage of propofol, sufentanil, remifentanil, and intraoperative vasoactive drug dosage were recorded to compare."( Effect of ketorolac tromethamine combined with dezocine prior administration on hemodynamics and postoperative analgesia in patients undergoing laparoscopic hernia repair.
Cai, Z; Fu, B; Kang, Y; Li, Y; Wang, J; Wu, Y, 2022
)
0.98
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
opioid analgesicA narcotic or opioid substance, synthetic or semisynthetic agent producing profound analgesia, drowsiness, and changes in mood.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
primary amino compoundA compound formally derived from ammonia by replacing one hydrogen atom by an organyl group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Dezocine Action Pathway3111

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Mu-type opioid receptorHomo sapiens (human)EC50 (µMol)0.03800.00000.32639.4000AID392933
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (16)

Processvia Protein(s)Taxonomy
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerMu-type opioid receptorHomo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathwayMu-type opioid receptorHomo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayMu-type opioid receptorHomo sapiens (human)
sensory perceptionMu-type opioid receptorHomo sapiens (human)
negative regulation of cell population proliferationMu-type opioid receptorHomo sapiens (human)
sensory perception of painMu-type opioid receptorHomo sapiens (human)
G protein-coupled opioid receptor signaling pathwayMu-type opioid receptorHomo sapiens (human)
behavioral response to ethanolMu-type opioid receptorHomo sapiens (human)
positive regulation of neurogenesisMu-type opioid receptorHomo sapiens (human)
negative regulation of Wnt protein secretionMu-type opioid receptorHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeMu-type opioid receptorHomo sapiens (human)
calcium ion transmembrane transportMu-type opioid receptorHomo sapiens (human)
cellular response to morphineMu-type opioid receptorHomo sapiens (human)
regulation of cellular response to stressMu-type opioid receptorHomo sapiens (human)
regulation of NMDA receptor activityMu-type opioid receptorHomo sapiens (human)
neuropeptide signaling pathwayMu-type opioid receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
G-protein alpha-subunit bindingMu-type opioid receptorHomo sapiens (human)
G protein-coupled receptor activityMu-type opioid receptorHomo sapiens (human)
beta-endorphin receptor activityMu-type opioid receptorHomo sapiens (human)
voltage-gated calcium channel activityMu-type opioid receptorHomo sapiens (human)
protein bindingMu-type opioid receptorHomo sapiens (human)
morphine receptor activityMu-type opioid receptorHomo sapiens (human)
G-protein beta-subunit bindingMu-type opioid receptorHomo sapiens (human)
neuropeptide bindingMu-type opioid receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (9)

Processvia Protein(s)Taxonomy
endosomeMu-type opioid receptorHomo sapiens (human)
endoplasmic reticulumMu-type opioid receptorHomo sapiens (human)
Golgi apparatusMu-type opioid receptorHomo sapiens (human)
plasma membraneMu-type opioid receptorHomo sapiens (human)
axonMu-type opioid receptorHomo sapiens (human)
dendriteMu-type opioid receptorHomo sapiens (human)
perikaryonMu-type opioid receptorHomo sapiens (human)
synapseMu-type opioid receptorHomo sapiens (human)
plasma membraneMu-type opioid receptorHomo sapiens (human)
neuron projectionMu-type opioid receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID588218FDA HLAED, lactate dehydrogenase (LDH) increase2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID588214FDA HLAED, liver enzyme composite activity2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID588219FDA HLAED, gamma-glutamyl transferase (GGT) increase2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID588215FDA HLAED, alkaline phosphatase increase2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID588216FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID588217FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID392934Intrinsic activity at human cloned mu opioid receptor at 100 uM by [35S]GTPgammaS binding assay relative to DAMGO2009Bioorganic & medicinal chemistry letters, Feb-15, Volume: 19, Issue:4
Discovery of mu-opioid selective ligands derived from 1-aminotetralin scaffolds made via metal-catalyzed ring-opening reactions.
AID392933Agonist activity at human cloned mu opioid receptor by [35S]GTPgammaS binding assay2009Bioorganic & medicinal chemistry letters, Feb-15, Volume: 19, Issue:4
Discovery of mu-opioid selective ligands derived from 1-aminotetralin scaffolds made via metal-catalyzed ring-opening reactions.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (135)

TimeframeStudies, This Drug (%)All Drugs %
pre-199029 (21.48)18.7374
1990's14 (10.37)18.2507
2000's7 (5.19)29.6817
2010's42 (31.11)24.3611
2020's43 (31.85)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.35

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.35 (24.57)
Research Supply Index5.29 (2.92)
Research Growth Index5.76 (4.65)
Search Engine Demand Index52.19 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (38.35)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials56 (39.44%)5.53%
Reviews11 (7.75%)6.00%
Case Studies0 (0.00%)4.05%
Observational1 (0.70%)0.25%
Other74 (52.11%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (10)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Use of Oxycodone in Multimodel Perioperative Analgesia of Bariatric Surgery and Its Effect on Inflammatory Factors [NCT05515822]Phase 490 participants (Anticipated)Interventional2022-10-01Not yet recruiting
Interventional Bronchoscopy Under Noninvasive Ventilation for Central Airway Stenosis [NCT02289586]40 participants (Anticipated)Interventional2014-07-31Recruiting
The Effects of Dezocine Pretreatment on Dexamethasone Induced Perineal Irritation [NCT02768168]80 participants (Actual)Interventional2016-05-31Completed
Cohort Study of Auricular Pressure Therapy for Intervention of Postoperative Pain of Hemorrhoidectiomy [NCT04111302]240 participants (Anticipated)Interventional2020-05-01Not yet recruiting
Efficacy of Dezocine for the Prevention of Catheter-related Bladder Discomfort [NCT03147066]Phase 496 participants (Actual)Interventional2017-09-01Completed
The Efficacy and Safety of Dezocine Pretreatment for Pain Relief in Acne Scar [NCT05861063]Phase 4105 participants (Anticipated)Interventional2023-02-11Recruiting
The Comparison of the Analgesic Effects of Dezocine and Sufentanil in Patient-controlled Analgesia After Laryngectomy [NCT06000137]129 participants (Actual)Interventional2022-02-10Completed
Effect of Dexmedetomidine Combined With Dezocine and Flubiprofen for Postoperative Intravenous Patient Controlled Analgesia After Colorectal Surgery [NCT03014713]Phase 450 participants (Anticipated)Interventional2016-09-30Recruiting
The Effectiveness of Sedation and Analgesia in Colonoscopy Treatment of Colorectal Polyps: a Single-center, Prospective, Randomized Controlled Study [NCT04906317]340 participants (Anticipated)Interventional2020-12-01Recruiting
The Effect of Doctor-nurse-patient Cooperative Analgesic Linkage Program on Movement Evoked Pain After Laparotomy for Patients With Hepatobiliary and Pancreatic Disease [NCT03823846]80 participants (Anticipated)Interventional2017-11-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]